Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment
Clinical trial NCT04435964 · COMPLETED
Trial details
- NCT number
- NCT04435964
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-25
- Primary completion
- 2023-02-28
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.